In last trading session, InMed Pharmaceuticals Inc (NASDAQ:INM) saw 3.08 million shares changing hands with its beta currently measuring 0.29. Company’s recent per share price level of $3.36 trading at $0.74 or 28.24% at ring of the bell on the day assigns it a market valuation of $4.05M. That closing price of INM’s stock is at a discount of -367.26% from its 52-week high price of $15.70 and is indicating a premium of 48.81% from its 52-week low price of $1.72. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.35 million shares which gives us an average trading volume of 39.76K if we extend that period to 3-months.
For InMed Pharmaceuticals Inc (INM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
Upright in the green during last session for gaining 28.24%, in the last five days INM remained trading in the green while hitting it’s week-highest on Wednesday, 05/14/25 when the stock touched $3.36 price level, adding 16.0% to its value on the day. InMed Pharmaceuticals Inc’s shares saw a change of -29.11% in year-to-date performance and have moved 22.81% in past 5-day. InMed Pharmaceuticals Inc (NASDAQ:INM) showed a performance of 27.27% in past 30-days. Number of shares sold short was 31503.0 shares which calculate 0.62 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 53.87% during past 5 years.
InMed Pharmaceuticals Inc (NASDAQ:INM)’s Major holders
Insiders are in possession of 0.34% of company’s total shares while institution are holding 10.54 percent of that, with stock having share float percentage of 10.57%. Investors also watch the number of corporate investors in a company very closely, which is 10.54% institutions for InMed Pharmaceuticals Inc that are currently holding shares of the company. SABBY MANAGEMENT, LLC is the top institutional holder at INM for having 0.31 million shares of worth $81571.0. And as of 2024-06-30, it was holding 3.1961 of the company’s outstanding shares.
The second largest institutional holder is VIRTU FINANCIAL LLC, which was holding about 86684.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.9017 of outstanding shares, having a total worth of $23000.0.
